| LRCX |
Report |
Revenue (FQ4/Jun-26) |
BEAT |
pred ~$6.78B vs. cons $6.67B |
MEDIUM |
| LRCX |
Report |
Non-GAAP EPS (FQ4/Jun-26) |
BEAT |
pred ~$1.73 vs. cons $1.69 |
MEDIUM |
| LRCX |
Report |
Non-GAAP Gross Margin (FQ4/Jun-26) |
IN-LINE |
pred ~50.7% vs. cons ~50.5% |
MEDIUM |
| LRCX |
Report |
CSBG / Services revenue (FQ4) |
BEAT |
pred ~$2.15B vs. cons ~$2.10B |
LOW |
| LRCX |
Guide |
Revenue guide (FQ1/Sep-26) |
BETTER |
guide ~$6.95B vs. cons ~$6.85B (Sep-26 qtr) |
LOW |
| LRCX |
Guide |
Non-GAAP EPS guide (FQ1/Sep-26) |
BETTER |
guide ~$1.78 vs. cons ~$1.74 (Sep-26 qtr) |
LOW |
| LRCX |
Guide |
Gross margin guide (FQ1/Sep-26) |
UNCHANGED |
guide ~50.5% vs. cons ~50.5% (Sep-26 qtr) |
MEDIUM |
| LRCX |
Guide |
2026 WFE view |
BETTER |
guide ~$140B+ vs. cons ~$138B (CY2026) |
MEDIUM |
| LRCX |
Guide |
2027 WFE / long-term model framing |
UNKNOWN |
guide qualitatively constructive (~growth yr) vs. cons cautious (CY2027) |
LOW |
| LRCX |
Guide |
China % of revenue trajectory |
LOWER |
guide China ~30% & declining vs. cons ~32% (Sep-26 qtr) |
MEDIUM |
| LRCX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
LOW |
| LRCX |
Return |
5-day cumulative residual |
+1.0% (FADE) |
A beat-and-raise into a ~38% drawdown likely sparks an oversold relief bounce day-1, but the out-period math works against durable follow-through: China guided down with down-payments at 4-yr lows and SK Hynix's ~47% rout keep memory-cycle fear alive, so implicit forward cuts and a broad AI/semis de-rating (AMAT/KLAC also cratering) drag the bounce back over the week unless a refreshed long-term model lands as a hard catalyst. |
LOW |